- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Optimizing the Payer/Provider Relationship for a Successful Annual Enrollment Period, Part 2
Experts discuss current trends in Medicare Advantage during the current annual enrollment period, best practices for communication, and gain clarity about the benefits and costs for both providers and beneficiaries.
In the latest Matters in Managed Care webinar, experts discussed current trends in Medicare Advantage during the current annual enrollment period, best practices for communication, and gain clarity about the benefits and costs for both providers and beneficiaries. They discussed the health system, provider, and payer perspectives.
Steve Evans, MD, vice president for quality and utilization management, Intermountain Healthcare, moderated the panel with:
- Judith Ford, MD, medical director, Intermountain Healthcare
- Othella Ann Jurani-Suarez, MD, medical director, Intermountain Healthcare
- Kristine Gates, government program sales director, SelectHealth
- Matt Maher, senior sales manager, Humana
- Sherry Stanislaw, general manager, officer, SCAN Health Plan
In segment 2, they discussed trends in Medicare Advantage.
Without IRA Fix, COA Warns Community Oncology Practices Will Shut Down
June 30th 2025Ted Okon, MBA, of the Community Oncology Alliance discusses how community oncology faces a revenue crisis due to the Inflation Reduction Act's impact on Medicare reimbursement, risking patient access to vital cancer treatments.
Read More
Blister Packs May Help Solve Medication Adherence Challenges and Lower Health Care Costs
June 10th 2025Julia Lucaci, PharmD, MS, of Becton, Dickinson and Company, discusses the benefits of blister packaging for chronic medications, advocating for payer incentives to boost medication adherence and improve health outcomes.
Listen
Many Patients Stop GLP-1s Before Reaching Target Dose: Hamlet Gasoyan, PhD
June 19th 2025Discontinuing the weight loss treatment before hitting the recommended maintenance dose contributes to low-value care despite provider follow-up and efforts to manage side effects, says Hamlet Gasoyan, PhD, Cleveland Clinic.
Read More
